Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Planned sale SVP, Chief Medical Officer sold 8,367 shares at $1.52 ($12,718)
  2. 4 Open-market sale CEO and President sold 37,733 shares at $1.52 ($57,354)
  3. 4 Grant or award Chief Commercial Officer acquired 303,300 shares (grant or award)
  4. 4 Grant or award Chief Accounting Officer acquired 223,950 shares (grant or award)
  5. 4 Grant or award SVP, Chief Operating Officer acquired 149,300 shares (grant or award)
  6. 4 Grant or award SVP, CFO and Treasurer acquired 149,300 shares (grant or award)
  7. 4 Grant or award SVP, Chief Legal Officer acquired 149,300 shares (grant or award)
  8. 4 Open-market sale CEO and President sold 46,489 shares at $1.68 ($78,102)
  9. 4 Open-market sale SVP, Chief Medical Officer sold 24,311 shares at $1.68 ($40,842)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award SVP, CFO and Treasurer acquired 370,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Director acquired 30,000 shares (grant or award)
  15. 4 Grant or award Director acquired 30,000 shares (grant or award)
  16. 4 Grant or award Director acquired 30,000 shares (grant or award)
  17. 4 Grant or award Director acquired 30,000 shares (grant or award)
  18. 4 Grant or award Director acquired 30,000 shares (grant or award)
  19. 4 Grant or award Director acquired 30,000 shares (grant or award)
  20. 4 Grant or award Director acquired 30,000 shares (grant or award)

Page 4 of 19 · 378 filings